Erratum to: Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
- PMID: 25589200
- DOI: 10.1007/s40259-015-0115-8
Erratum to: Vedolizumab: A Review of Its Use in Adult Patients with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Erratum for
-
Vedolizumab: a review of its use in adult patients with moderately to severely active ulcerative colitis or Crohn's disease.BioDrugs. 2015 Feb;29(1):57-67. doi: 10.1007/s40259-014-0113-2. BioDrugs. 2015. PMID: 25502899 Review.
Publication types
LinkOut - more resources
Full Text Sources
